Latest Curex News & Updates

See the latest news and media coverage for Curex. We track all announcements, press releases, and industry mentions in real time, all in one place.

Curex

Online allergy, eczema, asthma, and weight management clinic

getcurex.com

Headquarters: New York, United States
Founded year: 2019
Company type: Private company
Number of employees: 10–125
Industry: Healthcare Facilities & Services

Last updated Today

Latest news about Curex

In short: Curex released a large real-world study on telemedicine allergy drops and launched an at-home sublingual treatment for food allergies.

Company announcements

September 10 Curex

Curex explains treating food and environmental allergies with one SLIT formula

Sublingual immunotherapy can safely address multiple allergens simultaneously, supported by extensive safety data.

June 22 Curex

Curex explores peptide evidence for allergies

No human trials exist for any peptide in allergic disease; the evidence points to allergen immunotherapy as the effective treatment.

January 2 Curex

Curex summarizes research on sublingual immunotherapy

The post covers history, safety, efficacy, duration, and comparison to injections, citing numerous clinical trials.

19 March 2024 Curex

Curex explains why insurance does not cover allergy drops

Allergy drops lack FDA approval and are costly, leading insurers to deny coverage.

Media coverage

September 9 MSN

Allergy seasons are getting longer. New research shows at-home treatment can keep up.

As climate change extends pollen season by three weeks on average, a study of 23,000+ patient-years finds daily at-home...

August 13 The Manila Times

Curex Releases Largest Real-World Study Telemedicine Allergy Drops: High Adherence, Symptom Improvement

Quality-of-life improvements increased from 81% of patients reporting benefit at 12 to 18 months to more than 90% at 30 to 36 months, one of...

30 October 2024 Yahoo Finance

Curex Introduces a Safer, At-Home Alternative to Food Oral Immunotherapy

Miami, FL, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Curex, the leader in telemedicine allergy immunotherapy treatments, announces the launch of its innovative at-home Sublingual Immunotherapy...

6 April 2021 RAPS

Manhattan firm's "allergy drops" prompt CBER untitled letter

The US Food and Drug Administration's (FDA's) biologics division has delivered an untitled letter to a Manhattan-based firm for marketing sublingual "allergy drops" from its...

Never miss news about Curex

Track Curex and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Curex competitors & trending companies

Browse news for competitors to Curex and other trending companies.